Hypercalcemia at DLBCL Diagnosis May Be Associated with Adverse Impacts
Hypercalcemia at diagnosis of diffuse large B-cell lymphoma was found to be strongly correlated with adverse prognostic factors and a short diagnosis-to-treatment interval. (Source: CancerNetwork)
Source: CancerNetwork - May 5, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
First-in-Human Trial of TruUCAR GC027 in Relapsed/Refractory T-Cell ALL Announced
The first-in-human clinical trial for TruUCAR GC027 in relapsed or refractory T-cell acute lymphoblastic leukemia was announced by Gracell Biotechnologies. (Source: CancerNetwork)
Source: CancerNetwork - May 5, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Neil H. Baum, MD, on Telemedicine in Oncology
Baum spoke about the transition to telemedicine as a result of COVID-19 and the best practices for using the platform moving forward. (Source: CancerNetwork)
Source: CancerNetwork - May 5, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Uptake in Lung Cancer Screening May Depend on Modalities Provided
This study suggested that identifying which lung cancer screening options are generally more attractive to patients may increase screening. (Source: CancerNetwork)
Source: CancerNetwork - May 4, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Many Patients with Anal Cancer Experienced Chemoradiation Therapy Interruption and Noncompletion
A recent study published in JAMA Oncology revealed that quality improvement initiatives are necessary to optimize treatment and lessen chemotherapy interruption and noncompletion rates among patients with squamous cell anal carcinoma. (Source: CancerNetwork)
Source: CancerNetwork - May 4, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news
Strengths and Weakness of Decision Aids for Women Regarding Mammographic Screening
In this systematic review, researchers highlighted the strengths and weaknesses of existing decision aids for women with an average risk of breast cancer who are eligible for mammographic screening. (Source: CancerNetwork)
Source: CancerNetwork - May 4, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
NYC Patients with Cancer and COVID-19 Infection See Increased Rates of Fatality
Researchers in New York City reported a significant increase in case fatality in patients with cancer and COVID-19 compared with patients with COVID-19 who did not have cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 4, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Study Demonstrates Promise for Olaparib in Metastatic Castration-Resistant Prostate Cancer
Olaparib was found to be associated with longer progression-free survival and improved measures of response and patient-reported end points than either enzalutamide or abiraterone in men with metastatic castration-resistant prostate cancer. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Population Genomic Screening Efforts May Identify High-Risk Individuals Before Disease Onset
According to researchers, these observations suggest a potential need to modify the current framework for clinical risk disclosure. (Source: CancerNetwork)
Source: CancerNetwork - May 3, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Improved Risk Models Identify People at Higher than Normal Risk of Pancreatic Cancer
Researchers demonstrated that risk models that include established clinical, genetic, and circulating factors are better able to identify people at significantly higher than normal risk of pancreatic cancer over those using clinical factors alone. (Source: CancerNetwork)
Source: CancerNetwork - May 2, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Fiber Consumption May be Associated with Reduced Breast Cancer Risk
The results from this random-effects meta-analysis suggested that dietary fiber intake may decrease the risk of breast cancer, including both premenopausal and postmenopausal breast cancers. (Source: CancerNetwork)
Source: CancerNetwork - May 2, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Alterations in Genitourinary Cancer Care Due to COVID-19
In a webinar, a multidisciplinary team from Duke Cancer Center came together to discuss the differences in treating patients with genitourinary cancer as a result of the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - May 1, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
FDA Approves Daratumumab and Hyaluronidase-fihj for Multiple Myeloma
The FDA approved the use of daratumumab and hyaluronidase-fihj (Darzalex Faspro) in adult patients with newly diagnosed or relapsed/refractory multiple myeloma. (Source: CancerNetwork)
Source: CancerNetwork - May 1, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
Mathematical Model Predicts Outcomes in Prostate Cancer Therapy
The model was able to use data from each treatment cycle to estimate intratumor subpopulations and accurately predict the outcomes in each subsequent cycle. (Source: CancerNetwork)
Source: CancerNetwork - May 1, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
FDA Grants Priority Review to CC-486 for the Treatment of Acute Myeloid Leukemia
The FDA granted priority review to a new drug application for CC-486 for the maintenance treatment of adult patients with acute myeloid leukemia based on efficacy and safety results from the pivotal phase III QUAZAR AML-001 study. (Source: CancerNetwork)
Source: CancerNetwork - May 1, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
